T1	intervention 0 14	Weight lifting
T2	condition 59 69	lymphedema
T3	control 347 368	no exercise (control)
T4	location 528 540	Philadelphia
T5	total-participants 562 565	154
T6	eligibility 566 718	breast cancer survivors 1 to 5 years postunilateral breast cancer, with at least 2 lymph nodes removed and without clinical signs of BCRL at study entry
T10	total-participants 1226 1229	134
T12	iv-bin-percent 1347 1350	11%
T13	iv-bin-abs 1352 1353	8
T14	intervention-participants 1357 1359	72
T15	cv-bin-percent 1406 1409	17%
T16	cv-bin-abs 1411 1413	13
T17	control-participants 1417 1419	75
T18	outcome 1640 1659	incident BCRL onset
T19	iv-bin-percent 1664 1666	7%
T20	iv-bin-abs 1668 1669	3
T21	intervention-participants 1673 1675	45
T22	cv-bin-percent 1722 1725	22%
T23	cv-bin-abs 1727 1729	11
T24	control-participants 1733 1735	49
T25	outcome 1825 1853	Clinician-defined BCRL onset
T26	iv-bin-abs 1866 1867	1
T27	cv-bin-abs 1919 1920	3
T28	iv-bin-percent 1949 1953	1.5%
T29	cv-bin-percent 1957 1961	4.4%
T11	outcome 1323 1342	incident BCRL onset
